Low dose oral ketamine treatment on post-traumatic stress disorder (PTSD) (OKTOP): An open-label pilot study

被引：0
|
作者：
Quigley, Bonnie L. [1 ,2 ]
Can, Adem T. [1 ]
Dutton, Megan [1 ]
Gallay, Cyrana C. [1 ]
Forsyth, Grace [1 ]
Jones, Monique [1 ]
Randall, Fiona [1 ]
Wilson, Trish [1 ]
Lagopoulos, Jim [3 ]
Hermens, Daniel F. [1 ]
机构：
[1] Univ Sunshine Coast, Natl PTSD Res Ctr, Thompson Inst, Birtinya, Qld 4575, Australia
[2] Univ Sunshine Coast, Ctr Bioinnovat, Sippy Downs, Qld 4556, Australia
[3] Thompson Brain & Mind Healthcare, Maroochydore, Qld 4558, Australia
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2025年 / 93卷
关键词：
Ketamine; Low dose oral ketamine; Post-traumatic stress disorder; PTSD;
D O I：
10.1016/j.euroneuro.2025.01.003
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：17 / 18
页数：2
相关论文
共 50 条
  • [1] Olanzapine treatment for post-traumatic stress disorder: an open-label study
    Petty, F
    Brannan, S
    Casada, J
    Davis, LL
    Gajewski, V
    Kramer, GL
    Stone, RC
    Teten, AL
    Worchel, J
    Young, KA
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2001, 16 (06) : 331 - 337
  • [2] Preliminary, Open-Label, Pilot Study of Add-On Oral Δ9-Tetrahydrocannabinol in Chronic Post-Traumatic Stress Disorder
    Roitman, Pablo
    Mechoulam, Raphael
    Cooper-Kazaz, Rena
    Shalev, Arieh
    CLINICAL DRUG INVESTIGATION, 2014, 34 (08) : 587 - 591
  • [3] Short-term treatment of post-traumatic stress disorder with naltrexone: an open-label preliminary study
    Lubin, G
    Weizman, A
    Shmushkevitz, M
    Valevski, A
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2002, 17 (04) : 181 - 185
  • [4] Quetiapine as an adjunctive treatment for post-traumatic stress disorder: an 8-week open-label study
    Ahearn, EP
    Mussey, M
    Johnson, C
    Krohn, A
    Krahn, D
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2006, 21 (01) : 29 - 33
  • [5] An open-label pilot study of aripiprazole for male and female Veterans with chronic post-traumatic stress disorder who respond suboptimally to antidepressants
    Youssef, Nagy A.
    Marx, Christine E.
    Bradford, Daniel W.
    Zinn, Sandra
    Hertzberg, Michael A.
    Kilts, Jason D.
    Naylor, Jennifer C.
    Butterfield, Marian I.
    Strauss, Jennifer L.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2012, 27 (04) : 191 - 196
  • [6] Efficacy and Safety of Intranasal Esketamine in Patients With Treatment-Resistant Depression and Comorbid Chronic Post-traumatic Stress Disorder: Open-Label Single-Arm Pilot Study
    Rotharmel, Maud
    Benosman, Cherifa
    El-Hage, Wissam
    Berjamin, Caroline
    Ribayrol, Diane
    Guillin, Olivier
    Gaillard, Raphael
    Berkovitch, Lucie
    Moulier, Virginie
    FRONTIERS IN PSYCHIATRY, 2022, 13
  • [7] Nefazodone in post-traumatic stress disorder: results from six open-label trials
    Hidalgo, R
    Hertzberg, MA
    Mellman, T
    Petty, F
    Tucker, P
    Weisler, R
    Zisook, S
    Chen, S
    Churchill, E
    Davidson, J
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1999, 14 (02) : 61 - 68
  • [8] Post-Traumatic Stress Disorder (PTSD) in Trauma Patients
    Radow, Brandon
    Anderson, Nathaniel
    Richmond, Bryan K.
    AMERICAN SURGEON, 2025, 91 (02) : 292 - 299
  • [9] EFFECTIVENESS OF KETAMINE FOR THE TREATMENT OF POST-TRAUMATIC STRESS DISORDER - A SYSTEMATIC REVIEW AND META-ANALYSIS
    Almeida, Thales Marcon
    Silva, Ursula Raianny Lacerda da
    Pires, Jeully Pereira
    Borges, Isaac Neri
    Martins, Clara Rosa Muniz
    Cordeiro, Quirino
    Uchida, Ricardo R.
    CLINICAL NEUROPSYCHIATRY, 2024, 21 (01): : 22 - 31
  • [10] The Impact of Ketamine for Treatment of Post-Traumatic Stress Disorder: A Systematic Review With Meta-Analyses
    Sicignano, Dakota J.
    Kurschner, Ryan
    Weisman, Nissen
    Sedensky, Ava
    Hernandez, Adrian V.
    White, C. Michael
    ANNALS OF PHARMACOTHERAPY, 2024, 58 (07) : 669 - 677
12345